ArticleBMC endocrine disorders2026
Occupational heavy metal exposure and endocrine-metabolic biomarkers: a retrospective analysis of 34,595 screened individuals in Türkiye.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeavy metals and trace elements can act as endocrine-disrupting chemicals and have been linked to thyroid, glucose, lipid, and hepatic abnormalities. We aimed to explore associations between routinely measured metal concentrations and biochemical/endocrinological parameters in a large occupational screening dataset from Türkiye.
methodsRecords from 37,763 individuals evaluated at a national occupational and environmental diseases hospital between November 2021 and October 2023 were retrospectively reviewed; after prespecified exclusions, 34,595 unique participants were included. Metal measurements were performed in whole blood, serum, and urine samples as requested in routine surveillance; for each analyte, results were categorized as within or above the interpretive limit by the laboratory information system. Primary comparisons focused on arsenic, cadmium, lead, manganese, and zinc because of occupational relevance and sample size. Routine biochemistry, lipid profile, and thyroid function tests were extracted when available, and estimated glomerular filtration rate (eGFR, CKD‑EPI) was calculated.
resultsAmong participants with available thyroid function tests (n = 9,956), thyroid dysfunction was observed in 14.3% (subclinical hypothyroidism 11.9%). Among participants with available fasting glucose and/or HbA1c data (n = 20,738), diabetes mellitus and prediabetes criteria were met in 12.8% and 10.0%, respectively. In univariable comparisons, several metals above the interpretive limit were associated with differences in metabolic biomarkers, including lower HDL with elevated cadmium, lower HDL/LDL with elevated manganese, and higher ALT/AST and triglycerides with elevated zinc. Elevated metal strata differed in age and sex distribution. After within-metal false discovery rate correction, only a limited subset of biomarker differences remained significant.
conclusionAmong tested participants, thyroid dysfunction and dysglycemia were observed, and selected metal measurements above interpretive limits were associated with lipid and liver enzyme patterns. Given the clinically driven testing and limited covariate data, these findings should be interpreted as exploratory surveillance signals rather than workforce-level prevalence estimates. Heavy metal exposure may exert endocrine-disrupting effects on workers in relevant industries, particularly on thyroid function and glycemic regulation, suggesting that periodic surveillance of these parameters is warranted in exposure-prone workforces.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.